GC Biopharma secures first Latin American approval for BARYCELA Inj.

Clover Biopharmaceuticals reports positive US Phase I data for RSV re-vaccination in older adults

Pfizer and Valneva report strong Phase 3 results for Lyme disease vaccine candidate

Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform

Elaris FlexCo signs global licence agreement with Valneva

ECO Animal Health announces receipt of favourable USDA safety assessment for ECOVAXXIN MG poultry vaccine

Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens

Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial

Delonix Bioworks gets IND clearance for DX-104 in China

Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil

European Commission approves GSK's Arexvy for adults aged 18 and over

PhotonPharma adds Dr. William Warren to board

Clover Biopharmaceuticals enrols first participants in Phase 2 trial of respiratory combination vaccine candidates

GSK wins European Commission approval for Shingrix prefilled syringe

Sanofi agrees USD2.2bn acquisition of Dynavax to strengthen adult vaccine portfolio